Consent of Independent Registered Public Accounting Firm |
We consent to the incorporation by reference in the following Registration Statements: | ||||||||
(1) | Registration Statement (Form S-1 No. 333-204905) as filed on June 12, 2015, and amended on September 8, 2015, September 22, 2015, October 1, 2015, and October 13, 2015, | |||||||
(2) | Registration Statement (Form S-8 No. 333-207949) pertaining to the 2015 Omnibus Incentive Compensation Plan, | |||||||
(3) | Registration Statement (Form S-8 No. 333-211490) pertaining to the 2016 Equity Incentive Plan, | |||||||
(4) | Registration Statement (Form S-8 No. 333-211491) pertaining to the 2016 Employee Stock Purchase Plan, | |||||||
(5) | Registration Statement (Form S-1 No. 333-213676) as filed on September 16, 2016, | |||||||
(6) | Registration Statement (Form S-3 No. 333-214507) as filed on November 8, 2016, and amended on December 1, 2016, | |||||||
(7) | Registration Statement (Form S-3 No. 333-218252) as filed on May 26, 2017, | |||||||
(8) | Registration Statement (Form S-8 No. 333-226767) pertaining to the Amended and Restated 2016 Equity Incentive Plan, | |||||||
(9) | Registration Statement (Form S-3 No. 333-227227) as filed on September 7, 2018, and amended on October 2, 2018, | |||||||
(10) | Registration Statement (Form S-3 No. 333-229283) as filed on January 17, 2019, | |||||||
(11) | Registration Statement (Form S-3 No. 333-233978) filed on September 27, 2019, and amended on October 18, 2019, | |||||||
(12) | Registration Statement (Form S-4 No. 333-235666) filed on December 20, 2019 and amended on December 30, 2019, | |||||||
(13) | Registration Statement (Form S-3 No. 333-238197) filed on May 12, 2020, and | |||||||
(14) | Registration Statement (Form S-8 No. 333-241661) pertaining to the Third Amended and Restated 2016 Equity Incentive Plan and the 2016 Employee Stock Purchase Plan, | |||||||
(15) | Registration Statement (Form S-3 No. 333-254000) filed on March 8, 2021; | |||||||
(16) | Registration Statement (Form S-8 No. 333-256080) pertaining to Non-Qualified Stock Option Inducement Awards; | |||||||
(17) | Registration Statement (Form S-8 No. 333-256082) pertaining to the Third Amended and Restated 2016 Equity Incentive Plan; and | |||||||
(18) | Registration Statement (Form S-8 No. 333-256083) pertaining to the 2016 Employee Stock Purchase Plan. | |||||||
of our report dated March 2, 2022, with respect to the consolidated financial statements of Avalo Therapeutics, Inc. and subsidiaries included in this Annual Report (Form 10-K) of Avalo Therapeutics, Inc. for the year ended December 31, 2021. | ||||||||
/s/ Ernst & Young LLP | |||||
Baltimore, Maryland | |||||
March 2, 2022 |